Keywords: scios, wyeth, start, ph, ii, fiblast, partner

Scios And Wyeth Start Ph II With Fiblast

Article | 06 January 1997

Print This

- Scios and partner Wyeth-Ayerst have started a Phase II trial ofFiblast (trafermin; bFGF) in patients with peripheral vascular disease. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in